Alivira Animal Health is an API manufacturer based in India. It holds 2 active US drug master files and 11 valid CEPs across a filed portfolio of 12 molecules. Its filings concentrate with FDA (GH), Health Canada and ZAMRA (ZM). Its GMP standing is certified by CDSCO (India) and US FDA. Its most recent recorded inspection, by US FDA, closed on 22 September 2023 as VAI. Customs aggregates show $9.4M of exports covering 341 molecules to 49 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Visakhapatnam, India | 3011747378 |
| Gidc, India | Not on file |
| tal khambhatkansari 388 630anand, India | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Triclabendazole For Veterinary Use | EDQM | 2 |
| Albendazole | US FDA | 1 |
| Carprofen For Veterinary Use | EDQM | 1 |
| Diclazuril For Veterinary Use | EDQM | 1 |
| Febantel For Veterinary Use | EDQM | 1 |
| Fenbendazole For Veterinary Use | EDQM | 1 |
| Flubendazole | EDQM | 1 |
| Flunixin Meglumine For Veterinary Use | EDQM | 1 |
| Lufenuron For Veterinary Use | EDQM | 1 |
| Oxfendazole For Veterinary Use | EDQM | 1 |
| Triclabendazole | US FDA | 1 |
| Xylazine Hydrochloride For Veterinary Use | EDQM | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| FDA (GH) | 27 | None |
| Health Canada | 4 | None |
| ZAMRA (ZM) | 2 | None |
| CDSCO (India) | None | 2 |
| US FDA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $1.5M | 9 |
| 2025 | Not reported | $9.4M | 49 |
| 2024 | Not reported | $5.4M | 42 |
| 2023 | Not reported | $7.6M | 48 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Alivira Animal Health comes back tiered against every other supplier able to file there.
Start for free